Resources
Materials created during the set-up of PROTECT-CH may be accessed using the links below. All materials may be used whole or in part for any research purpose. Note: there may be minor inconsistencies due to materials being at different stages of completion at time of stopping the study.
- Consent Guidance Booklet
- Consent Training Module (mp4)
- Consent Training Module
- Outbreak and Eligibility Flow
- Participant Poster
- PROTECT-CH Data Entry Final
- PROTECT-CH Background to Trial (mp4)
- PROTECT-CH Background to Trial
- PROTECT-CH Care Home Set-Up Guidance Booklet
- PROTECT-CH Care Home Set-Up Slide deck
- PROTECT-CH Consent & Enrolment Poster
- PROTECT-CH Consent and Eligibility Overview
- PROTECT-CH COVID-19 Outbreak Guidance Booklet
- PROTECT-CH COVID-19 Outbreak Guidance Checklist
- PROTECT-CH Data Protection (mp4)
- PROTECT-CH Data Protection
- PROTECT-CH General Practitioner (GP) Training
- PROTECT-CH Introduction (mp4)
- PROTECT-CH Introduction
- PROTECT-CH Participant Video
- PROTECT-CH Principal Investigator (PI) Training Module (mp4)
- PROTECT-CH Research Nurse (RN) Data Entry User Guide
- PROTECT-CH Research Nurse (RN)
- PROTECT-CH Research Nurse (RN) (mp4)
- PROTECT-CH Safety Pocket-size Card
- PROTECT-CH Safety (mp4)
- PROTECT-CH Safety
- PROTECT-CH Therapy Ciclesonide
- PROTECT-CH Therapy Niclosamide
- PROTECT-CH Trial Specific Good Clinical Practice (GCP) (mp4)
- PROTECT-CH Trial Specific Good Clinical Practice (GCP)
- Safety Reporting Flowchart
- Site Initiation Visit
- Trial Assessments & Follow-up Training Module
- Trial Assessments & Follow-up Training Module (mp4)
MHRA CTA Acknowledgement Letter- MHRA CTA Notice of Non-Acceptance
- IRAS 294832 Favourable Opinion with Additional Conditions
- HRA Revised Approval Letter Correspondence
- FW IRAS 294832. Application Valid for REC Review
- CTA Acceptance of Amended Request
- 294832 Initial Assessment 20210430
- 294832 Approval 20210520 (1)
- 294832 Approval 20210607 (v2)
- 294832 Acknowledgement for Documentation Received Following a FOwC